- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
Alternate Short Strategy: Put Protection for Less (Part II)
-
Amgen May Have a Winner on Its Hands
-
Amgen's D-mab Debate
-
FDA Calendar Updates: Amgen, Bayer, Biogen, Noveko, Peplin, Transdel
-
Winners and Losers Since the 6/12 Market High
-
Closing Update for Wednesday July 8
-
Is IBB the Best Biotech ETF?
-
6 Ways to Short the Obama Health Plan
-
Smaller Pharma Wins the 'Most Valuable' Race
-
51 Option Ideas for Bears
-
FDA Calendar Updates: Amgen, Amicus, Oncothyreon and Medarex
-
25 Bullish Option Ideas
-
Redefining Pharma as Biotech Dominates Industry's Growth
-
15 Possible Healthcare Breakout Stocks
-
Amgen's Better than Expected Portfolio Outlook
-
Biotech Set to Dominate Drug Industry Growth
-
Playing Health Care Reform with Biotech ETFs IBB and XBI
-
Fast Money Recap: Mister Softee No More? (6/16/09)
-
Proposed Legislation Could Boost Medicare's Ability to Extract Savings on Drugs
-
Wednesday's Healthcare Market Movers
-
Cord Blood Stocks: Seven Ways to Invest
-
Lee Ainslie's Maverick Capital Sells CVS Caremark in Favor of Walgreens: 13F Filing Q1 2009
-
Two Potential Mega Biotech Deals Fuel Industry Hopes
-
Blue Ridge Capital: One Hedge Fund That's Done With Gold
-
GM Leaving the Dow (Soon): Likely Replacements
-
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
-
FDA, Clinical Trial Updates: MAP Pharma, Cytokinetics, Hemispherx Post Big Gains
-
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
-
Swine Flu: Trade Smartly, Beware the Hype
-
Weekly Street Sentiment: Where Have All the Reasonable People Gone?
-
Amgen Q1 2009 Performance Analysis: Shares Likely Present Compelling Value
-
Wall Street Breakfast: Must-Know News
-
Earnings Preview: Amgen
-
CNBC's Fast Money - What to Do About Yahoo? (4/20/09)
-
State Street Convertible Bond ETF: Another Useful Tool for Income-Oriented Investors
-
First Convertible Bond ETF Comes to Market
-
Passport Capital's Q408: Mostly Selling
-
Opportunities in Healthcare: Highly Defensive Stocks
-
Rentec Ratchets Up Positions in Q408
-
That Was Not a 2:1 Split in BBH
-
Weekly Street Sentiment: Sometimes the Trend Is Not Your Friend